{
    "nctId": "NCT01916317",
    "briefTitle": "Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer",
    "officialTitle": "Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Operable Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 1600,
    "primaryOutcomeMeasure": "\u2022 To assess the in-vivo ability of local anesthetics agents like lignocaine to decrease the dissemination of cancer cells during surgery and improve the disease free interval",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. All women with operable breast cancer planned for upfront surgery\n2. Histologically proven or clinically suspicious breast cancer\n\nExclusion Criteria:\n\n1. Previous history of lumpectomy or incision biopsy\n2. Distant metastases\n3. Neoadjuvant Chemotherapy\n4. History of allergy to drugs (lignocaine)\n5. High risk factors precluding the use of lignocaine\n6. Previous history of cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}